Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Street Color: Schlumberger, Canada's Competition Bureau Reach Consent Agreement on ChampionX Takeover
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Street Color: Schlumberger, Canada's Competition Bureau Reach Consent Agreement on ChampionX Takeover
Jul 16, 2025 6:55 AM
09:39 AM EDT, 07/16/2025 (MT Newswires) --
Price: 35.12, Change: +0.04, Percent Change: +0.11
Previous page:
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Next page:
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- Kane Biotech ( KNBIF ) on Thursday said it received approval from the Internal Review Board (IRB) of the University of Miami Health System to launch a clinical study of Kane's prototype DispersinB acne cleanser for the treatment of mild to moderate cases of acne vulgaris. The trial, which is expected to start...
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Mar 13, 2025
11:12 AM EDT, 03/13/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Thursday it is recalling one batch of levetiracetam in 0.75% sodium chloride injection, 1,000 mg/100 mL single-dose infusion bags across the US. The company said it is recalling the product due to the incorrect labeling of the infusion bag which reads as levetiracetam in 0.82% sodium chloride injection...
SentinelOne Exceeds Q4 Revenue Expectations, But Guidance Concerns Linger, Oppenheimer Says
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- SentinelOne's ( S ) fiscal Q4 revenue exceeded expectations and despite posting strong results near-term investor concerns persist due to lower-than-anticipated guidance for the next fiscal year, Oppenheimer said in a note on Thursday. The company demonstrated strong enterprise adoptions with 1,411 customers generating over $100,000 in annual recurring revenue with 40% of...
Mallinckrodt, Endo Enter $6.7 Billion Merger Deal as Drug Makers Plan New US Listing
Mar 13, 2025
11:01 AM EDT, 03/13/2025 (MT Newswires) -- Mallinckrodt and Endo are set to merge in a cash-and-stock deal valued at $6.7 billion, with the drug makers set to list shares of the new firm on the New York Stock Exchange. Shareholders in Endo, which makes sterile injectables and generic pharmaceuticals, will receive $80 million in cash and a 49.9% stake...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP